• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

DEPO:US

15.2750 USD 0.0750 0.49%

As of 10:28:31 ET on 09/02/2014.

Company Profile for Depomed Inc (DEPO)

DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation.

Contact Information

Depomed Inc

7999 Gateway Blvd
Suite 300
Newark, CA 94560
United States
Phone: 510-744-8000

Key Executives for Depomed Inc (DEPO)

James A Schoeneck "Jim"President/CEOAugust J MorettiSenior VP/CFO/Investor Relations
Richard Scott ShivelySenior VP/Chief Commercial OfcrSrinivas G RaoSenior VP/Chief Medical Officer
Matthew M GoslingSenior VP/General CounselThadd M VargasSenior VP:Business Dev
Jeff P CoonVP:Human ResourcesKevin D WeberVP:Marketing
Steve L GrecoVP:SalesGerd G KochendoerferVP:Technical Dev & Quality
Julian N SternSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil